Cx Institutional Novartis Ag Transaction History

Cx Institutional

  • $2.06 Billion
  • Q1 2024

A detailed history of Cx Institutional transactions in Novartis Ag stock. As of the latest transaction made, Cx Institutional holds 10,202 shares of NVS stock, worth $1.09 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,202
Previous 10,255 0.52%
Holding current value
$1.09 Million
Previous $1.04 Million 4.73%
% of portfolio
0.05%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$95.27 - $108.47 $5,049 - $5,748
-53 Reduced 0.52%
10,202 $986,000
Q2 2023

Jul 26, 2023
SELL
$92.52 - $104.91 $8,604 - $9,756
-93 Reduced 0.9%
10,255 $1.03 Million
Q1 2023

May 04, 2023
BUY
$80.03 - $92.81 $11,684 - $13,550
146 Added 1.43%
10,348 $952,000
Q1 2022

May 09, 2022
BUY
$80.11 - $90.62 $110,151 - $124,602
1,375 Added 15.58%
10,202 $895,000
Q4 2021

Jan 18, 2022
SELL
$79.7 - $88.13 $109,587 - $121,178
-1,375 Reduced 13.48%
8,827 $772,000
Q4 2020

Jan 12, 2021
SELL
$78.07 - $94.43 $1,014 - $1,227
-13 Reduced 0.13%
10,202 $963,000
Q3 2020

Oct 13, 2020
SELL
$82.14 - $91.0 $2,546 - $2,821
-31 Reduced 0.3%
10,215 $888,000
Q2 2020

Aug 06, 2020
BUY
$80.93 - $91.1 $13,434 - $15,122
166 Added 1.65%
10,246 $895,000
Q4 2019

Jan 21, 2020
SELL
$84.35 - $95.37 $1,349 - $1,525
-16 Reduced 0.16%
10,080 $954,000
Q3 2019

Oct 10, 2019
SELL
$85.54 - $94.26 $2,480 - $2,733
-29 Reduced 0.29%
10,096 $877,000
Q2 2019

Jul 17, 2019
SELL
$75.4 - $92.8 $20,207 - $24,870
-268 Reduced 2.58%
10,125 $925,000
Q1 2019

Apr 03, 2019
BUY
$75.32 - $86.15 $24,554 - $28,084
326 Added 3.24%
10,393 $999,000
Q4 2018

Jan 14, 2019
BUY
$73.66 - $82.02 $741,535 - $825,695
10,067 New
10,067 $864,000

Others Institutions Holding NVS

# of Institutions
1,346
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email